Dr. Hsiung’s work focuses on understanding the neurological basis of cognition and the pathological mechanisms that can lead to dementia. Dedicated to transforming research discoveries into tools and therapies, Dr. Hsiung is currently testing biomarkers and cognitive assessments tools to help clinicians identify the early phases of this degenerative brain disease. Dr. Hsiung has been elected President of the Consortium of Canadian Centres for Clinical Cognitive Research (C5R), which coordinates and streamlines clinical trials across a network of specialized clinics across Canada. Dr. Hsiung is also the lead for the Frontotemporal Dementia team in the Canadian Consortium on Neurodegeneration and Aging (CCNS), a Canada-wide network of over 350 researchers aiming to research the cause and cure of dementing disorders, as well as improving the care of patients suffering from dementia. The current study collects data on patients with a range of neurodegenerative cognitive disorders using specialized tests on mental functioning, as well as magnetic resonance imaging data, to help predict dementia risk and provide early intervention to slow cognitive decline.